Close monitoring is recommended, particularly during the initial weeks or after dose increases, to ensure tolerability and detect potential complications like bile duct stones or pancreatitis
One of the most widely used artificial sweeteners, sucralose, was the topic of a study where the authors concluded that sucralose was not carcinogenic and that current intake levels are well below established safety limits (Berry et al
The drug was first approved in 2010, but the problem was that a patient had to inject it daily
ADVANCED BIONUTRITIONALS GLP-1 PLUS: AN INGREDIENT-FIRST RESPONSE TO THESE TRENDS Against the backdrop of rising interest in GLP-1, Advanced BioNutritionals has introduced GLP-1 Plus a formulation built to meet the moment with a transparency-first approach
Nat Rev Endocrinol (2011) 7(9):5056
References Liepinsh, E., Kalvinsh, I